Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Claudia Duran-Aniotz"'
Autor:
Kevin Blanco, Stefanny Salcidua, Paulina Orellana, Tania Sauma-Pérez, Tomás León, Lorena Cecilia López Steinmetz, Agustín Ibañez, Claudia Duran-Aniotz, Rolando de la Cruz
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-16 (2023)
Abstract Mild cognitive impairment (MCI) is often considered an early stage of dementia, with estimated rates of progression to dementia up to 80–90% after approximately 6 years from the initial diagnosis. Diagnosis of cognitive impairment in demen
Externí odkaz:
https://doaj.org/article/0a2e8de3929c4c25a49843bfc3b03be6
Publikováno v:
Frontiers in Aging Neuroscience, Vol 15 (2023)
Women’s contributions to science have been consistently underrepresented throughout history. Despite many efforts and some progresses being made to reduce gender inequity in science, pursuing an academic career across disciplines, including Alzheim
Externí odkaz:
https://doaj.org/article/7cbcde92aa364e0bbe87f416cdfff81d
Autor:
María Josefina Escobar, Carolina Panesso, Eduardo Franco Chalco, Andrea Cardemil, Alejandra Grez, Pilar Del Río, Juan Pablo Del Río, Pilar Vigil, Claudia Duran-Aniotz
Publikováno v:
Psykhe (2023)
La pandemia por COVID-19 que afectó al mundo entero ha traído desafíos complejos, especialmente para las familias con niños y adolescentes. Se ha descrito que el impacto del encierro o confinamiento de la pandemia sobre la salud mental ha sido de
Externí odkaz:
https://doaj.org/article/a37ce4030af949e2862c69746163dece
Autor:
Joaquín Araya-Arriagada, Sebastián Garay, Cristóbal Rojas, Claudia Duran-Aniotz, Adrián G. Palacios, Max Chacón, Leonel E. Medina
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Alzheimer’s disease (AD) is one of the most significant health challenges of our time, affecting a growing number of the elderly population. In recent years, the retina has received increased attention as a candidate for AD biomarkers sinc
Externí odkaz:
https://doaj.org/article/076a9febedd147f7aa3c7dc4cac30371
Autor:
Mychael V. Lourenco, Wyllians Vendramini Borelli, Claudia Duran‐Aniotz, Eduardo R. Zimmer, Shamyr Sulyvan deCastro
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 9, Iss 1, Pp n/a-n/a (2023)
Abstract Alzheimer's disease (AD) is a global health issue. Because AD is a condition demanding effective management, its socioeconomic burden is immense and threatens the health systems of both low‐ and middle‐income (LMIC) and high‐income (HI
Externí odkaz:
https://doaj.org/article/c2496b4bd7e14435a6c5fe8b7c2e2bc0
Autor:
Gary O’Donovan, Olga L. Sarmiento, Philipp Hessel, Graciela Muniz-Terrera, Claudia Duran-Aniotz, Agustín Ibáñez
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
Background and objectiveMore research is required to understand associations of body mass index (BMI) and sarcopenia with cognition, especially in Latin America. The objective of this study was to investigate associations of BMI and sarcopenia with m
Externí odkaz:
https://doaj.org/article/bb02ed19ba42456083063d7521d3696e
Autor:
Claudia Duran-Aniotz, Ines Moreno-Gonzalez, Nazaret Gamez, Nelson Perez-Urrutia, Laura Vegas-Gomez,, Claudio Soto, Rodrigo Morales
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-13 (2021)
Abstract Amyloid-β (Aβ) misfolding is one of the hallmark pathological features of Alzheimer’s disease (AD). AD can manifest with diverse symptomatology including variable rates of cognitive decline, duration of clinical disease, and other detrim
Externí odkaz:
https://doaj.org/article/bfa76f68cd5c402bb124838cc6ffb05d
Autor:
Rodrigo Morales, Claudia Duran-Aniotz, Javiera Bravo-Alegria, Lisbell D. Estrada, Mohammad Shahnawaz, Ping-Ping Hu, Carlos Kramm, Diego Morales-Scheihing, Akihiko Urayama, Claudio Soto
Publikováno v:
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-16 (2020)
Abstract Previous studies showed that injection of tissue extracts containing amyloid-β (Aβ) aggregates accelerate amyloid deposition in the brain of mouse models of Alzheimer’s disease (AD) through prion-like mechanisms. In this study, we evalua
Externí odkaz:
https://doaj.org/article/0abd87e9c0524d7d9af4eb8a1dead7ab
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/18e6dcae28ea489ab1d4905a78a82560
Autor:
Natalia Ogonowski, Stefanny Salcidua, Tomas Leon, Nayaret Chamorro-Veloso, Cristian Valls, Constanza Avalos, Alejandro Bisquertt, Miguel E. Rentería, Paulina Orellana, Claudia Duran-Aniotz
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2022)
The rate of progression from Mild Cognitive Impairment (MCI) to Alzheimer's disease (AD) is estimated at >10% per year, reaching up to 80–90% after 6 years. MCI is considered an indicator of early-stage AD. In this context, the diagnostic screening
Externí odkaz:
https://doaj.org/article/b13c8068518444fc9700238ed722f437